NDC 66689-009-01 - Ibuprofen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66689-009
- Requested NDC
- 66689-009-01
- Package NDCs from labels
- 66689-009-01, 66689-009-50
- Manufacturer
- VistaPharm, Inc.
- Effective date
- 2019-11-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| IBUPROFEN ORAL SUSPENSION USP 100 mg/5 mL | VistaPharm, Inc. | 2019-11-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Ibuprofen - Cardinal Health | Cardinal Health | 2018-10-26 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66689-009-01 | ML - Milliliter | 66689-009 | 0607df43-62ad-450e-a5f3-6e1bae247e3b | 1 | 2013-02-13 |
| 66689-009-50 | ML - Milliliter | 66689-009 | 75797402-6277-490c-b6e6-fcd37a224737 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Redness Relief | GLYCERIN, NAPHAZOLINE HCL | Pharmadel LLC | 4c113bb9-814f-d92d-e063-6294a90a8302 | 2026-03-30 | Warnings | PDC6A3C0OX |
| Moisture Oyster | GLYCERIN | Moisture Oyster Inc | 4e45317a-437f-4d88-e063-6294a90a98d0 | 2026-03-30 | Warnings | PDC6A3C0OX |
| Ibuprofen | IBUPROFEN | Bryant Ranch Prepack | 1ebf94fb-76b6-4c01-be1b-575062827545 | 2026-03-30 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN ORAL | Aurobindo Pharma Limited | 758eeb45-e599-4c1a-969d-8fa33f27bf14 | 2026-03-30 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| ibuprofen pm | DIPHENHYDRAMINE CITRATE, IBUPROFEN | Rite Aid Corporation | d9eefb84-cc2e-4deb-a1c0-a7c21929f5ac | 2026-03-27 | Warnings | WK2XYI10QM |
| Aveeno Skin Relief Healing | GLYCERIN | Kenvue Brands LLC | 345fdde5-700b-7103-e063-6394a90a0e3e | 2026-03-27 | Warnings | PDC6A3C0OX |
| Ibuprofen Oral | IBUPROFEN ORAL | Camber Consumer Care Inc | b2dd4863-613e-4a41-98c1-3191e41b8463 | 2026-03-26 | Warnings | WK2XYI10QM |
| Crocodile Tears Lubricant Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Crocodile Tears LLC | 4df29336-ea0c-0484-e063-6294a90a685a | 2026-03-26 | Warnings | PDC6A3C0OX 3NXW29V3WO |
| Ibuprofen Dye Free | IBUPROFEN | WALMART INC. | 2b04d255-a1df-4698-9b5a-ad7a12205e1b | 2026-03-25 | Warnings | WK2XYI10QM |
| Artificial Tears Lubricant Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | KC Pharmaceuticals, Inc | 4de5c844-85ca-ff9f-e063-6394a90ac12c | 2026-03-25 | Warnings | PDC6A3C0OX 3NXW29V3WO |
| Ibuprofen | IBUPROFEN | Preferred Pharmaceuticals Inc. | 32edaf34-046e-4ded-8bee-493a0019d6bd | 2026-03-25 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | REMEDYREPACK INC. | dda7645f-1666-4c1f-b974-01add2ea79ac | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Lemon Glycerin | GLYCERIN | Dynarex Corporation | 99fc00ea-9d55-0380-e053-2995a90a2c0b | 2026-03-24 | Warnings | PDC6A3C0OX |
| ADVIL ALLERGY SINUS | CHLORPHENIRAMINE MALEATE, IBUPROFEN, PSEUDOEPHEDRINE HCL | Haleon US Holdings LLC | ecd6ea11-8b34-01b4-cbd9-901ba7a8f6e2 | 2026-03-23 | Warnings | WK2XYI10QM |
| Ibuprofen PM | IBUPROFEN AND DIPHENHYDRAMINE HCL | Whole Foods Market, INC. | 4db58605-9cc7-e57e-e063-6294a90ab800 | 2026-03-23 | Warnings | WK2XYI10QM |
| IBUPROFEN Infants | IBUPROFEN | Sun Pharmaceutical Industries, Inc. | bc816597-a85a-4143-9f99-bb0699ca57c5 | 2026-03-23 | Warnings | WK2XYI10QM |
| Dolex Flex | IBUPROFEN | Pharmadel LLC | 0543420d-a250-065d-e063-6294a90a005e | 2026-03-20 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Westminster Pharmaceuticals, LLC | 6f7e255f-48c9-4366-8725-7f8cbe1bb75a | 2026-03-20 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | NuCare Pharmaceuticals, Inc. | 2e0f74a5-b8f3-fc81-e063-6394a90a647a | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| DUAL ACTION BACK PAIN RELIEVER | ACETAMINOPHEN, IBUPROFEN | Meijer, Inc. | 8d9a0c56-ef22-45a6-8b1d-d2b2f3247210 | 2026-03-19 | Warnings | WK2XYI10QM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.